Knowledge@Wharton June 12, 2019
Johnson & Johnson’s John Whang discusses a new research effort in partnership with Apple to see whether wearables can be used to help with early detection of atrial fibrillation.
A personal experience with the tedium and bureaucracy of health care stands as a metaphor for John Whang, who is leading a new research study by Johnson & Johnson into early detection of a potentially deadly heart condition known as atrial fibrillation.
Whang, a physician, described taking his daughter for a routine eye exam to check her visual acuity. They got in the car, drove to the doctor’s office and waited 40 minutes to see the doctor, who needed maybe 10 minutes to conduct the exam. Then they drove home.
“Soup...
Today's Sponsors
Today's Sponsor